Literature DB >> 32200349

Golgi Acidification by NHE7 Regulates Cytosolic pH Homeostasis in Pancreatic Cancer Cells.

Koen M O Galenkamp1, Paulina Sosicka2, Michael Jung1, M Victoria Recouvreux1, Yijuan Zhang1, Matthew R Moldenhauer1, Giovanni Brandi3, Hudson H Freeze2, Cosimo Commisso4.   

Abstract

Cancer cells reprogram their metabolism to meet elevated energy demands and favor glycolysis for energy production. This boost in glycolytic flux supports proliferation, but also generates acid in the form of hydrogen ions that must be eliminated from the cytoplasm to maintain the alkaline intracellular pH (pHi) associated with transformation. To cope with acid production, tumor cells employ ion transport systems, including the family of sodium-hydrogen exchangers (NHE). Here, we identify NHE7 as a novel regulator of pHi in pancreatic ductal adenocarcinoma (PDAC). We determine that NHE7 suppression causes alkalinization of the Golgi, leading to a buildup of cytosolic acid that diminishes tumor cell fitness mainly through the dysregulation of actin. Importantly, NHE7 knockdown in vivo leads to the abrogation of tumor growth. These results identify Golgi acidification as a mechanism to control pHi and point to the regulation of pHi as a possible therapeutic vulnerability in PDAC. SIGNIFICANCE: NHE7 regulates cytosolic pH through Golgi acidification, which points to the Golgi as a "proton sink" for metabolic acid. Disruption of cytosolic pH homeostasis via NHE7 suppression compromises PDAC cell viability and tumor growth.See related commentary by Ward and DeNicola, p. 768.This article is highlighted in the In This Issue feature, p. 747. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32200349      PMCID: PMC7269827          DOI: 10.1158/2159-8290.CD-19-1007

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   38.272


  45 in total

1.  Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins.

Authors:  J Llopis; J M McCaffery; A Miyawaki; M G Farquhar; R Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

Review 2.  Tumour acidosis: from the passenger to the driver's seat.

Authors:  Cyril Corbet; Olivier Feron
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

3.  Isolation and properties of fibroblast mutants overexpressing an altered Na+/H+ antiporter.

Authors:  A Franchi; E Cragoe; J Pouysségur
Journal:  J Biol Chem       Date:  1986-11-05       Impact factor: 5.157

4.  Monensin A acid complexes as a model of electrogenic transport of sodium cation.

Authors:  Adam Huczyński; Jan Janczak; Daniel Lowicki; Bogumil Brzezinski
Journal:  Biochim Biophys Acta       Date:  2012-04-30

Review 5.  Brefeldin A: insights into the control of membrane traffic and organelle structure.

Authors:  R D Klausner; J G Donaldson; J Lippincott-Schwartz
Journal:  J Cell Biol       Date:  1992-03       Impact factor: 10.539

6.  Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Authors:  Eric A Collisson; Anguraj Sadanandam; Peter Olson; William J Gibb; Morgan Truitt; Shenda Gu; Janine Cooc; Jennifer Weinkle; Grace E Kim; Lakshmi Jakkula; Heidi S Feiler; Andrew H Ko; Adam B Olshen; Kathleen L Danenberg; Margaret A Tempero; Paul T Spellman; Douglas Hanahan; Joe W Gray
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

7.  Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.

Authors:  Khalid O Alfarouk; Daniel Verduzco; Cyril Rauch; Abdel Khalig Muddathir; H H Bashir Adil; Gamal O Elhassan; Muntaser E Ibrahim; Julian David Polo Orozco; Rosa Angela Cardone; Stephan J Reshkin; Salvador Harguindey
Journal:  Oncoscience       Date:  2014-12-18

8.  Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.

Authors:  Huai-Qiang Ju; Haoqiang Ying; Tian Tian; Jianhua Ling; Jie Fu; Yu Lu; Min Wu; Lifeng Yang; Abhinav Achreja; Gang Chen; Zhuonan Zhuang; Huamin Wang; Deepak Nagrath; Jun Yao; Mien-Chie Hung; Ronald A DePinho; Peng Huang; Rui-Hua Xu; Paul J Chiao
Journal:  Nat Commun       Date:  2017-02-24       Impact factor: 14.919

9.  Quantitative Variations with pH of Actin Depolymerizing Factor/Cofilin's Multiple Actions on Actin Filaments.

Authors:  Hugo Wioland; Antoine Jegou; Guillaume Romet-Lemonne
Journal:  Biochemistry       Date:  2018-12-18       Impact factor: 3.162

Review 10.  What is pH regulation, and why do cancer cells need it?

Authors:  Pawel Swietach
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

View more
  12 in total

Review 1.  New insights into the role of the Golgi apparatus in the pathogenesis and therapeutics of human diseases.

Authors:  Wooseon Choi; Shinwon Kang; Jiyoon Kim
Journal:  Arch Pharm Res       Date:  2022-09-30       Impact factor: 6.010

2.  Acid-Base Equilibrium and Self-Association in Relation to High Antitumor Activity of Selected Unsymmetrical Bisacridines Established by Extensive Chemometric Analysis.

Authors:  Michał Kosno; Tomasz Laskowski; Joanna E Frackowiak; Agnieszka Potęga; Agnieszka Kurdyn; Witold Andrałojć; Julia Borzyszkowska-Bukowska; Katarzyna Szwarc-Karabyka; Zofia Mazerska
Journal:  Molecules       Date:  2022-06-21       Impact factor: 4.927

Review 3.  The interactive role of inflammatory mediators and metabolic reprogramming in pancreatic cancer.

Authors:  Yuuki Ohara; Paloma Valenzuela; S Perwez Hussain
Journal:  Trends Cancer       Date:  2022-05-05

4.  Cytosolic pH regulates proliferation and tumour growth by promoting expression of cyclin D1.

Authors:  Lisa Maria Koch; Eivind Salmorin Birkeland; Stefania Battaglioni; Xiao Helle; Mayura Meerang; Stefanie Hiltbrunner; Alfredo J Ibáñez; Matthias Peter; Alessandra Curioni-Fontecedro; Isabelle Opitz; Reinhard Dechant
Journal:  Nat Metab       Date:  2020-10-19

5.  A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction.

Authors:  Bobby G Ng; Paulina Sosicka; François Fenaille; Annie Harroche; Sandrine Vuillaumier-Barrot; Mindy Porterfield; Zhi-Jie Xia; Shannon Wagner; Michael J Bamshad; Marie-Christine Vergnes-Boiteux; Sophie Cholet; Stephen Dalton; Anne Dell; Thierry Dupré; Mathieu Fiore; Stuart M Haslam; Yohann Huguenin; Tadahiro Kumagai; Michael Kulik; Katherine McGoogan; Caroline Michot; Deborah A Nickerson; Tiffany Pascreau; Delphine Borgel; Kimiyo Raymond; Deepti Warad; Heather Flanagan-Steet; Richard Steet; Michael Tiemeyer; Nathalie Seta; Arnaud Bruneel; Hudson H Freeze
Journal:  Am J Hum Genet       Date:  2021-05-07       Impact factor: 11.025

6.  Na+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer.

Authors:  Xin Zhou; Manman Jiang; Zhihong Liu; Mengmeng Xu; Nannan Chen; Ziyu Wu; Changji Gu; Eugene Chin; Xiaodong Yang
Journal:  J Oncol       Date:  2021-11-01       Impact factor: 4.375

7.  The Golgi as a "Proton Sink" in Cancer.

Authors:  Koen M O Galenkamp; Cosimo Commisso
Journal:  Front Cell Dev Biol       Date:  2021-05-13

Review 8.  Adaptation of the Golgi Apparatus in Cancer Cell Invasion and Metastasis.

Authors:  Sarah Bui; Isabel Mejia; Begoña Díaz; Yanzhuang Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-10

Review 9.  Targeting the Interplay between Cancer Metabolic Reprogramming and Cell Death Pathways as a Viable Therapeutic Path.

Authors:  Elisabetta Iessi; Rosa Vona; Camilla Cittadini; Paola Matarrese
Journal:  Biomedicines       Date:  2021-12-18

10.  SLC4A2 anion exchanger promotes tumour cell malignancy via enhancing net acid efflux across golgi membranes.

Authors:  Elham Khosrowabadi; Antti Rivinoja; Maija Risteli; Anne Tuomisto; Tuula Salo; Markus J Mäkinen; Sakari Kellokumpu
Journal:  Cell Mol Life Sci       Date:  2021-07-19       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.